185 related articles for article (PubMed ID: 37425141)
1. Engaging with the Private Sector for Noncommunicable Disease Prevention and Control: Is it Possible to Create "Shared Value?".
Collins TE; Akselrod S; Mahy L; Poznyak V; Berlina D; Hatefi A; Allen L
Ann Glob Health; 2023; 89(1):46. PubMed ID: 37425141
[TBL] [Abstract][Full Text] [Related]
2. Non-communicable disease governance in the era of the sustainable development goals: a qualitative analysis of food industry framing in WHO consultations.
Lauber K; Ralston R; Mialon M; Carriedo A; Gilmore AB
Global Health; 2020 Aug; 16(1):76. PubMed ID: 32847604
[TBL] [Abstract][Full Text] [Related]
3. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
Buse K; Tanaka S; Hawkes S
Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
[TBL] [Abstract][Full Text] [Related]
4. Addressing NCDs: Challenges From Industry Market Promotion and Interferences.
Tangcharoensathien V; Chandrasiri O; Kunpeuk W; Markchang K; Pangkariya N
Int J Health Policy Manag; 2019 May; 8(5):256-260. PubMed ID: 31204441
[TBL] [Abstract][Full Text] [Related]
5. Systems Thinking as a Framework for Analyzing Commercial Determinants of Health.
Knai C; Petticrew M; Mays N; Capewell S; Cassidy R; Cummins S; Eastmure E; Fafard P; Hawkins B; Jensen JD; Katikireddi SV; Mwatsama M; Orford J; Weishaar H
Milbank Q; 2018 Sep; 96(3):472-498. PubMed ID: 30277610
[TBL] [Abstract][Full Text] [Related]
6. Strategies to expand corporate autonomy by the tobacco, alcohol and sugar-sweetened beverage industry: a scoping review of reviews.
Hoe C; Weiger C; Minosa MKR; Alonso F; Koon AD; Cohen JE
Global Health; 2022 Feb; 18(1):17. PubMed ID: 35164801
[TBL] [Abstract][Full Text] [Related]
7. "Big" Food, Tobacco, and Alcohol: Reducing Industry Influence on Noncommunicable Disease Prevention Laws and Policies Comment on "Addressing NCDs: Challenges From Industry Market Promotion and Interferences".
Reeve B; Gostin LO
Int J Health Policy Manag; 2019 Jul; 8(7):450-454. PubMed ID: 31441282
[TBL] [Abstract][Full Text] [Related]
8. Understanding Structure and Agency as Commercial Determinants of Health Comment on "How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention".
Lee K; Crosbie E
Int J Health Policy Manag; 2020 Jul; 9(7):315-318. PubMed ID: 32613804
[TBL] [Abstract][Full Text] [Related]
9. Assessing the association between Corporate Financial Influence and implementation of policies to tackle commercial determinants of non-communicable diseases: A cross-sectional analysis of 172 countries.
Allen LN; Wigley S; Holmer H
Soc Sci Med; 2022 Mar; 297():114825. PubMed ID: 35228150
[TBL] [Abstract][Full Text] [Related]
10. Reducing the Role of the Food, Tobacco, and Alcohol Industries in Noncommunicable Disease Risk in South Africa.
Delobelle P; Sanders D; Puoane T; Freudenberg N
Health Educ Behav; 2016 Apr; 43(1 Suppl):70S-81S. PubMed ID: 27037150
[TBL] [Abstract][Full Text] [Related]
11. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.
Jailobaeva K; Falconer J; Loffreda G; Arakelyan S; Witter S; Ager A
Global Health; 2021 Jun; 17(1):68. PubMed ID: 34187499
[TBL] [Abstract][Full Text] [Related]
12. Multi-sectoral action in non-communicable disease prevention policy development in five African countries.
Juma PA; Mapa-Tassou C; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Oluwasanu M; Mbanya JC; Nkhata MJ; Asiki G; Kyobutungi C
BMC Public Health; 2018 Aug; 18(Suppl 1):953. PubMed ID: 30168391
[TBL] [Abstract][Full Text] [Related]
13. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries.
Moodie R; Stuckler D; Monteiro C; Sheron N; Neal B; Thamarangsi T; Lincoln P; Casswell S;
Lancet; 2013 Feb; 381(9867):670-9. PubMed ID: 23410611
[TBL] [Abstract][Full Text] [Related]
14. The double burden of neoliberalism? Noncommunicable disease policies and the global political economy of risk.
Glasgow S; Schrecker T
Health Place; 2016 May; 39():204-11. PubMed ID: 27132687
[TBL] [Abstract][Full Text] [Related]
15. How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention.
Lencucha R; Thow AM
Int J Health Policy Manag; 2019 Sep; 8(9):514-520. PubMed ID: 31657174
[TBL] [Abstract][Full Text] [Related]
16. Curbing the Rise of Noncommunicable Diseases in Uganda: Perspectives of Policy Actors.
Meghani A; Ssemugabo C; Pariyo G; Hyder AA; Rutebemberwa E; Gibson DG
Glob Health Sci Pract; 2021 Mar; 9(1):149-159. PubMed ID: 33795366
[TBL] [Abstract][Full Text] [Related]
17. Non-communicable disease prevention policy process in five African countries.
Juma PA; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Mapa-Tassou C; Oluwasanu M; Oladepo O; Abiona O; Nkhata MJ; Wisdom JP; Mbanya JC
BMC Public Health; 2018 Aug; 18(Suppl 1):961. PubMed ID: 30168393
[TBL] [Abstract][Full Text] [Related]
18. "The architecture of the state was transformed in favour of the interests of companies": corporate political activity of the food industry in Colombia.
Mialon M; Gaitan Charry DA; Cediel G; Crosbie E; Baeza Scagliusi F; Pérez Tamayo EM
Global Health; 2020 Oct; 16(1):97. PubMed ID: 33046110
[TBL] [Abstract][Full Text] [Related]
19. On the Perils of Universal and Product-Led Thinking Comment on "How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention".
Herrick C
Int J Health Policy Manag; 2020 May; 9(5):209-211. PubMed ID: 32563222
[TBL] [Abstract][Full Text] [Related]
20. A conceptual framework for investigating the impacts of international trade and investment agreements on noncommunicable disease risk factors.
Schram A; Ruckert A; VanDuzer JA; Friel S; Gleeson D; Thow AM; Stuckler D; Labonte R
Health Policy Plan; 2018 Jan; 33(1):123-136. PubMed ID: 29106574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
